Joseph S A, Walker D W
Department of Physiology, Monash University, Clayton, Victoria, Australia.
J Appl Physiol (1985). 1990 Nov;69(5):1903-11. doi: 10.1152/jappl.1990.69.5.1903.
We investigated the effect of increasing the synaptic concentration of catecholamines released from central pathways on breathing movements and electrocortical (ECoG) activity in fetal sheep in utero. In 11 trials (9 fetuses) intravenous infusion of the noradrenergic uptake inhibitor desipramine (DMI) resulted in an initial increase in the incidence of breathing movements from 47.8 +/- 2.2%/h to a maximum of 77.9 +/- 5.5%/h (P less than 0.05) followed by a subsequent decrease to 18.8 +/- 2.7%/h (P less than 0.05), which was associated with a decrease in the incidence of low-voltage ECoG activity. Mean breath amplitude also increased after DMI infusion from 5.8 +/- 0.2 mmHg to a peak of 8.9 +/- 0.9 mmHg (P less than 0.05). In five fetuses, intravenous injection of the alpha 1-receptor antagonist prazosin 30 min after the start of the DMI infusion blocked the increase of breath amplitude observed when DMI was given alone. Intracisternal infusion of 6-hydroxydopamine (6-OHDA, which causes an initial displacement of transmitter stores followed by a neurotoxic action) in six fetuses caused an increase in mean breath amplitude from 6.6 +/- 0.3 mmHg (control) to 22.3 +/- 5.5 mmHg (P less than 0.05) and a prolonged episode of breathing movements (168.5 +/- 47.2 min). The incidence of low-voltage ECoG activity was also increased significantly. A second infusion of 6-OHDA, 2 days after the first, had no effect on breathing movements or ECoG activities. The two treatments with 6-OHDA also resulted in a significant reduction in the response to intravenous infusion of DMI, indicating that endogenous release of norepinephrine had been reduced by the neurotoxin. These results suggest that 1) there is normally some tonic release of norepinephrine from central pathways, but this release is insufficient to stimulate sustained fetal breathing, and 2) accumulation in the synaptic cleft of catecholamines from central neurons is able to stimulate fetal breathing and promote low-voltage ECoG activity. Possible mechanisms that normally limit the activity of central catecholamine pathways before birth are discussed.
我们研究了增加子宫内胎羊中枢途径释放的儿茶酚胺突触浓度对呼吸运动和脑电图(ECoG)活动的影响。在11次试验(9只胎儿)中,静脉输注去甲肾上腺素能摄取抑制剂地昔帕明(DMI)导致呼吸运动发生率最初从47.8±2.2%/小时增加到最高77.9±5.5%/小时(P<0.05),随后降至18.8±2.7%/小时(P<0.05),这与低电压ECoG活动发生率的降低相关。DMI输注后平均呼吸幅度也从5.8±0.2 mmHg增加到峰值8.9±0.9 mmHg(P<0.05)。在5只胎儿中,在DMI输注开始30分钟后静脉注射α1受体拮抗剂哌唑嗪,可阻断单独给予DMI时观察到的呼吸幅度增加。向6只胎儿脑池内输注6-羟基多巴胺(6-OHDA,其导致递质储存最初移位,随后产生神经毒性作用)使平均呼吸幅度从6.6±0.3 mmHg(对照)增加到22.3±5.5 mmHg(P<0.05),并使呼吸运动持续时间延长(168.5±47.2分钟)。低电压ECoG活动的发生率也显著增加。在第一次输注6-OHDA 2天后进行第二次输注,对呼吸运动或ECoG活动没有影响。两次6-OHDA治疗还导致对静脉输注DMI的反应显著降低,表明神经毒素已减少了去甲肾上腺素的内源性释放。这些结果表明:1)通常中枢途径有一些去甲肾上腺素的紧张性释放,但这种释放不足以刺激胎儿持续呼吸;2)中枢神经元释放的儿茶酚胺在突触间隙的积聚能够刺激胎儿呼吸并促进低电压ECoG活动。文中讨论了出生前正常限制中枢儿茶酚胺途径活性的可能机制。